Jude Fitzgibbon

10.4k total citations
112 papers, 4.2k citations indexed

About

Jude Fitzgibbon is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Jude Fitzgibbon has authored 112 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 39 papers in Pathology and Forensic Medicine and 38 papers in Hematology. Recurrent topics in Jude Fitzgibbon's work include Lymphoma Diagnosis and Treatment (37 papers), Acute Myeloid Leukemia Research (35 papers) and Viral-associated cancers and disorders (17 papers). Jude Fitzgibbon is often cited by papers focused on Lymphoma Diagnosis and Treatment (37 papers), Acute Myeloid Leukemia Research (35 papers) and Viral-associated cancers and disorders (17 papers). Jude Fitzgibbon collaborates with scholars based in United Kingdom, United States and Germany. Jude Fitzgibbon's co-authors include Tim Lister, Jamie Cavenagh, Silvia Montoto, Matthew L. Smith, Carolyn Owen, T. Andrew Lister, David M. Hunt, Michael J. Barnett, Nicholas Katsanis and Elizabeth Fisher and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jude Fitzgibbon

110 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jude Fitzgibbon United Kingdom 37 1.7k 1.3k 1.1k 965 932 112 4.2k
Finbarr E. Cotter United Kingdom 38 2.6k 1.5× 848 0.6× 1.2k 1.0× 1.3k 1.3× 872 0.9× 111 5.0k
Rita Shaknovich United States 37 2.9k 1.7× 489 0.4× 1.2k 1.0× 1.1k 1.2× 561 0.6× 89 4.6k
Edward Fox United States 32 2.1k 1.2× 646 0.5× 748 0.7× 802 0.8× 321 0.3× 94 4.1k
Isidro Sánchez‐García Spain 36 2.7k 1.6× 693 0.5× 381 0.3× 1.3k 1.4× 465 0.5× 115 4.4k
Teresa Palomero United States 29 3.5k 2.0× 1.1k 0.8× 590 0.5× 1.0k 1.1× 383 0.4× 61 5.4k
Toshiya Inaba Japan 37 2.6k 1.5× 1.7k 1.3× 219 0.2× 799 0.8× 548 0.6× 124 4.6k
Edward A. Fox United States 33 4.8k 2.7× 1.0k 0.8× 973 0.9× 1.7k 1.7× 662 0.7× 53 7.4k
Vundavalli V. Murty United States 40 4.4k 2.5× 585 0.4× 1.2k 1.1× 1.9k 1.9× 632 0.7× 109 7.2k
Peter D. Aplan United States 48 4.4k 2.5× 2.3k 1.7× 387 0.3× 899 0.9× 617 0.7× 155 6.4k
Dan Grandér Sweden 50 3.9k 2.2× 568 0.4× 569 0.5× 1.7k 1.8× 670 0.7× 125 6.5k

Countries citing papers authored by Jude Fitzgibbon

Since Specialization
Citations

This map shows the geographic impact of Jude Fitzgibbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jude Fitzgibbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jude Fitzgibbon more than expected).

Fields of papers citing papers by Jude Fitzgibbon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jude Fitzgibbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jude Fitzgibbon. The network helps show where Jude Fitzgibbon may publish in the future.

Co-authorship network of co-authors of Jude Fitzgibbon

This figure shows the co-authorship network connecting the top 25 collaborators of Jude Fitzgibbon. A scholar is included among the top collaborators of Jude Fitzgibbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jude Fitzgibbon. Jude Fitzgibbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duran‐Ferrer, Martí, Diego Mallo, Ferran Nadeu, et al.. (2025). Fluctuating DNA methylation tracks cancer evolution at clinical scale. Nature. 645(8081). 764–773. 2 indexed citations
2.
Wang, Shenqiu, S. Parsa, Man Jiang, et al.. (2024). SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma. The Journal of Experimental Medicine. 221(10). 5 indexed citations
3.
Nagy, Ákos, Jacob Househam, Ann‐Marie Baker, et al.. (2024). Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center Lymphoma. Modern Pathology. 37(5). 100465–100465. 4 indexed citations
4.
Kumar, Emil, Koorosh Korfi, Findlay Bewicke‐Copley, et al.. (2024). CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma. British Journal of Haematology. 205(5). 1804–1809. 1 indexed citations
5.
6.
Tummala, Hemanth, Amanda J. Walne, Findlay Bewicke‐Copley, et al.. (2020). A frameshift variant in specificity protein 1 triggers superactivation of Sp1-mediated transcription in familial bone marrow failure. Proceedings of the National Academy of Sciences. 117(29). 17151–17155. 4 indexed citations
7.
Larrea, Erika, Marta Fernández‐Mercado, José Afonso Guerra‐Assunção, et al.. (2020). Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma. International Journal of Molecular Sciences. 21(22). 8795–8795. 2 indexed citations
8.
Wang, Jun, Eleni Maniati, James A. Heward, et al.. (2016). Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma. Cancer Research. 76(16). 4861–4871. 72 indexed citations
9.
Tawana, Kiran & Jude Fitzgibbon. (2016). CEBPA-Associated Familial Acute Myeloid Leukemia (AML). 4 indexed citations
10.
Okosun, Jessica, Graham Packham, & Jude Fitzgibbon. (2014). Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignancies. Expert Opinion on Investigational Drugs. 23(10). 1321–1332. 7 indexed citations
11.
Bödör, Csaba, Aline Renneville, Matthew Smith, et al.. (2012). Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica. 97(6). 890–894. 64 indexed citations
12.
Pearce, Daniel J., Robert W. Wilkinson, Claire Crafter, et al.. (2009). AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo. Cancer Research. 69(10). 4150–4158. 62 indexed citations
13.
Owen, Carolyn, Cynthia L. Toze, Donna L. Forrest, et al.. (2008). Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood. 112(12). 4639–4645. 168 indexed citations
14.
Jüliger, Simone, Heidi Goenaga‐Infante, Tim Lister, Jude Fitzgibbon, & Simon P. Joel. (2007). Chemosensitization of B-Cell Lymphomas by Methylseleninic Acid Involves Nuclear Factor-κB Inhibition and the Rapid Generation of Other Selenium Species. Cancer Research. 67(22). 10984–10992. 32 indexed citations
15.
Last, Karena, et al.. (2006). The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Annals of Oncology. 17(5). 773–779. 30 indexed citations
16.
Smith, Matthew, Lan‐Lan Smith, Nigel J. Bainton, et al.. (2005). Development of a human acute myeloid leukaemia screening panel and consequent identification of novel gene mutation in FLT3 and CCND3. British Journal of Haematology. 128(3). 318–323. 28 indexed citations
17.
Fitzgibbon, Jude, Lan‐Lan Smith, Manoj Raghavan, et al.. (2005). Association between Acquired Uniparental Disomy and Homozygous Gene Mutation in Acute Myeloid Leukemias. Cancer Research. 65(20). 9152–9154. 178 indexed citations
18.
Davies, Andrew, Claire Taylor, Andrew Clear, et al.. (2005). A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia. 19(8). 1459–1465. 50 indexed citations
19.
Smith, Matthew L., Jamie Cavenagh, Tim Lister, & Jude Fitzgibbon. (2004). Mutation ofCEBPAin Familial Acute Myeloid Leukemia. New England Journal of Medicine. 351(23). 2403–2407. 205 indexed citations
20.
Summers, Karin E., Andrew Davies, Janet Matthews, et al.. (2002). The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real‐time polymerase chain reaction. British Journal of Haematology. 118(2). 563–566. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Finbarr E. Cotter Breakdown of academic impact, for papers by Rita Shaknovich Breakdown of academic impact, for papers by Edward Fox Breakdown of academic impact, for papers by Isidro Sánchez‐García Breakdown of academic impact, for papers by Teresa Palomero Breakdown of academic impact, for papers by Toshiya Inaba Breakdown of academic impact, for papers by Edward A. Fox Breakdown of academic impact, for papers by Vundavalli V. Murty Breakdown of academic impact, for papers by Peter D. Aplan Breakdown of academic impact, for papers by Dan Grandér
Rankless by CCL
2026